Minor Power Alley Stuff: Verona Pharma Shareholders Have Approved Rahway’s ~$10 Billion Acquisition Offer — Closing, Next, On October 7.

As expected, and at this point, immaterial to Merck. But it does build out the COPD franchise appreciably. [With my early July 2025 backgrounder on it, here.]

Here’s the official notice (and again, we will be off-grid when it closes); do see here:

…On September 24, 2025, Verona Pharma‘s shareholders approved the acquisition by Merck & Co., Inc. through its subsidiary, Vol Holdings LLC, for $107 per American Depository Share, totaling approximately $10 billion.

The transaction, structured as a scheme of arrangement under English law, awaits the High Court of Justice’s sanction, with the effective date expected to be October 7, 2025, pending certain closing conditions….

Now you know. Have a great weekend, one and all!

नमस्ते